Oncotelic Therapeutics Inc (OTLC): FDA granted CA4P rare pediatric designat...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Friday, 04/30/2021 10:23:50 AM

Friday, April 30, 2021 10:23:50 AM

FDA granted CA4P rare pediatric designation for pediatric melanoma in 2020 and OXi4503 rare pediatric designation for pediatric ALL

Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:00:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 01:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 02:30:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:00:34 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/13/2023 01:25:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 01:15:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 01:25:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!